Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA1c < 7% with no hypoglycaemia and no weight gain over 2years

DSpace Repository

Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA1c < 7% with no hypoglycaemia and no weight gain over 2years

Author: Gallwitz, B.; Rosenstock, J.; Emser, A.; von Eynatten, M.; Woerle, H-J.
Tübinger Autor(en):
Gallwitz, Baptist
Published in: International Journal of Clinical Practice (2013), Bd. 67, H. 4, S. 317-321
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/ijcp.12101
ISSN: 1368-5031
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)